NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the NAPLEX exam with a comprehensive quiz featuring multiple-choice questions and in-depth explanations. Build your pharmacological knowledge and increase your chances of passing the pharmacist licensure examination!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

Belatacept is indicated for patients with what specificity?

EBV seropositive patients only
Patients with no history of autoimmune diseases
Patients with a history of diabetes
EBV seronegative patients only

The correct answer is: EBV seropositive patients only

Belatacept is a medication used for immunosuppression in patients who have had a kidney transplant. The drug works by blocking certain immune cells to prevent organ rejection. However, belatacept can increase the risk of developing post-transplant lymphoproliferative disorder (PTLD), a serious condition that is associated with the Epstein-Barr virus (EBV). Therefore, belatacept is specifically indicated for EBV seropositive patients to monitor and manage the risk of PTLD. This is why the correct answer is A. Options B, C, and D are incorrect because belatacept is not indicated based on the absence or presence of autoimmune diseases, history of diabetes, or EBV seronegative status. The primary consideration for the use of belatacept is the patient's EBV seropositive status due to the potential risk of PTLD associated with this medication.